IKCC Global Patient Survey on Kidney Cancer

Generating evidence to help reduce the global burden of kidney cancer.

programmes graphic v2

IKCC Global Patient Survey on Kidney Cancer

To improve collective understanding, IKCC collaborates with Partner Organisations to administer a biennial Global Patient Survey on Kidney Cancer.

The results help patient organisations locally and IKCC globally create evidence-based education, awareness and advocacy programs. Global Patient Survey results have been published in scientific manuscripts, presented to healthcare professionals and decision-makers at medical conferences, informed educational resources, and helped guide World Kidney Cancer Day campaigns.

Thank you to the patients, survivors, and carers who have completed the survey.

Now Open: 2026-2027 IKCC Global Patient Survey on Kidney Cancer

The 2026-2027 IKCC Global Patient Survey on Kidney Cancer (GPS) will be open from 24 September till 20 November 2026. People affected by kidney cancer are invited to share their experiences.

This marks 10 years of collecting data specific to the experiences of people living with kidney cancer, providing a decade of data. It will be possible to track positive and negative trends, demonstrate changes over time, and use patient insights to guide future advocacy, education, and support programs.

The GPS is open to everyone who has lived experience with kidney cancer, whether they have received the diagnosis or are a carer to someone who has. People who completed previous surveys are invited to participate again.

The survey is available in 18 languages and can be found here.

Questions about the GPS? Read the Frequently Asked Questions below.

2024-2025

2024-2025 Global Patient Survey on Kidney Cancer

Find the results from the 2024-2025 Global Patient Survey on Kidney Cancer in the Highlights Report.

Download the Report
2022

2022 Global Patient Survey on Kidney Cancer

Find the results from the 2022 Global Patient Survey on Kidney Cancer in the Highlights Report.

Download the Report
2020

2020 Global Patient Survey on Kidney Cancer

Find the results from the 2020 Global Patient Survey on Kidney Cancer in the Highlights Report.

Download the Report
2018

2018 Global Patient Survey on Kidney Cancer

Find the results from the 2018 Global Patient Survey on Kidney Cancer in the Highlights Report.

Download the Report

FAQs

2026-2027 IKCC Global Patient Survey on Kidney Cancer

What is the Global Patient Survey on Kidney Cancer (GPS)?

The 2026-2027 IKCC Global Patient Survey on Kidney Cancer is a patient-centred survey designed to identify geographic differences in patients’ experiences. It highlights best practices and unmet needs related to patients’ access to care, assesses quality of life, determines the prevalence of shared decision-making, and measures involvement in clinical trials. It is done biennially.

This marks 10 years of collecting data specific to the experiences of people living with kidney cancer, providing a decade of data. It will be possible to track positive and negative trends, demonstrate changes over time, and use patient insights to guide future advocacy, education, and support programs.

When will the survey be open?

The survey will open on 24 September and close on 20 November.

How many languages will the GPS be available in?

The survey will be available in 18 languages including:

  • Arabic
  • Chinese (Simplified)
  • English (UK)
  • English (US)
  • French
  • French (Canadian)
  • German
  • Hindi
  • Italian
  • Japanese
  • Korean
  • Polish
  • Portuguese
  • Portuguese (Brazilian)
  • Spanish
  • Swahili
  • Swedish
  • Turkish

Who can complete the GPS?

The survey is open to anyone who has lived experience with kidney cancer, whether they have received the diagnosis or are a carer to someone who has. People who completed previous surveys are invited to participate again.

How long does the GPS take? Does it all need to be completed at once?

The GPS takes approximately 15 – 20 minutes to complete. If it can’t all be completed at once, participants can save their responses part-way and return to complete the survey later by simply exiting and returning to the survey page. This happens automatically using browser cookies

When will the results be available?

After the GPS closes on 20 November, the data will be analysed, and in 2027 the results will be shared in Reports that look at trends, themes, and geographic variations and measure progress on our goal of reducing the burden of kidney cancer. In addition, Country-Specific Reports will be created when more than 100 participants from one country complete the survey.

Why is the survey done? Why every 2 years?

The information gathered in the GPS helps local patient organisations and IKCC understand the patient experience and how it is changing over time. With the information gathered, organisations can create education, awareness and advocacy programs that respond to the needs of people affected by kidney cancer.

Conducting the survey biennially (every 2 years) helps patient organisations and IKCC understand how the patient experience is changing over time, track trends and demonstrate changes.

What if someone completed a survey in the past? Can they participate again?

Yes! People who completed previous surveys are invited to participate again.

Why is it important for many people from my country to participate?

Understanding how experiences of patients in one country compare to global averages can help with planning and prioritising activities to advocate for local improvement.

Additionally, Country-Specific Reports are created when more than 100 participants from one country complete the survey. These results can help support health technology assessment and efforts to improve access to treatment and care. Results from Country-Specific Reports can also be submitted to local publications and conferences in partnership with local health professionals and other experts. This can be done in the form of written submissions, abstracts, posters and more. Results can also inform local awareness and fundraising campaigns.